A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.
Lenti MV, Ribaldone DG, Borrelli de Andreis F, Vernero M, Barberio B, De Ruvo M, Savarino EV, Kav T, Blesl A, Franzoi M, Gröchenig HP, Pugliese D, Ianiro G, Porcari S, Cammarota G, Gasbarrini A, Spagnuolo R, Ellul P, Foteinogiannopoulou K, Koutroubakis I, Argyriou K, Cappello M, Jauregui-Amezaga A, Demarzo MG, Silvestris N, Armuzzi A, Sottotetti F, Bertani L, Festa S, Eder P, Pedrazzoli P, Lasagna A, Vanoli A, Gambini G, Santacroce G, Rossi CM, Delliponti M, Klersy C, Corazza GR, Di Sabatino A; European Consortium for the study of immune checkpoint inhibitor-induced colitis.
Lenti MV, et al. Among authors: vernero m.
ESMO Open. 2024 Jul;9(7):103632. doi: 10.1016/j.esmoop.2024.103632. Epub 2024 Jul 5.
ESMO Open. 2024.
PMID: 38970840
Free PMC article.